By Heather Brennan, Ph.D.
General Manager, Global Markets
Over a decade ago, we set out on a mission to be the voice of women worldwide and create Femtech solutions inspired by you, to meet your individual needs
Today, after more than 12 years of putting women first in the market, we are now witnessing how the decision to focus on women’s needs has defined our path and shaped the future of Women’s Health. Putting your safety as our #1 priority and the cause behind everything we do, we are proud to share the astonishing results of our commitment to you.
Together, we would like to celebrate the milestone of what we call the Motiva® Standard:
- 3 years of US Motiva IDE clinical trial data submitted to the FDA (Food and Drug Administration)
- 3 million Motiva Implants in the market in 12+ years
- Consistently less than 1% device-related complications.
So, what do these astonishing results mean for you?
3 years of US Motiva IDE clinical data collected
The latest results of the Motiva US IDE study evaluating the performance of Motiva implants add to the data collected over 12 years and from over 3 million implants placed in women worldwide. Dr. Caroline Glicksman, the first woman to lead as a Medical Director of an FDA breast implant study, highlighted that the consistency in the clinical outcomes from year two to year three is incredibly promising with no increase in capsular contracture or rupture (suspected or confirmed) in this study period. This not only provides a new standard in breast implants being made available to women in the United States, but also further confirms the safety of our solutions to women worldwide.
Dr. Glicksman, said: “These results are the latest evidence of the performance of Motiva implants, adding to data collected over 12 years and from over three million implants placed in markets globally. We look forward to this new standard in breast implants being made available to women in the United States.”
3 million implants in the market over the last 12+ years
This means the voice of women worldwide has been heard. We have been able to share our Femtech solutions with many women around the world who are empowered to make the right choice on their journey of health, happiness, and confidence. We would like to take this opportunity to thank you for being part of this journey, as you are the inspiration and motivation behind everything we do. We look forward to continuing to support many more confident, powerful Motiva Girls!
Less than 1% of device-related complications
For over a decade, we have used the power of science, engineering, and technology to create innovative breast solutions for Women’s Health. As a result, over the last 12 years, the rate of device-related complications such as capsular contracture, rupture, and inflammation has remained remarkably low. The clinical evidence represents our strong commitment to bringing you safe solutions in your choices around breast health.
We thank you for your support as we continue to shape the future of Women’s Health together!
